{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:55:59Z","timestamp":1792662959398,"version":"4.5.0"},"reference-count":46,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,6,20]],"date-time":"2021-06-20T00:00:00Z","timestamp":1624147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Cachexia is a disorder associated with several pathologies, including cancer. In this paper, we describe how cachexia is induced in myotubes by a metabolic shift towards fermentation, and the block of this metabolic modification prevents the onset of the cachectic phenotype. Cachectic myotubes, obtained by the treatment with conditioned medium from murine colon carcinoma cells CT26, show increased glucose uptake, decreased oxygen consumption, altered mitochondria, and increased lactate production. Interestingly, the block of glycolysis by 2-deoxy-glucose or lactate dehydrogenase inhibition by oxamate prevents the induction of cachexia, thus suggesting that this metabolic change is greatly involved in cachexia activation. The treatment with 2-deoxy-glucose or oxamate induces positive effects also in mitochondria, where mitochondrial membrane potential and pyruvate dehydrogenase activity became similar to control myotubes. Moreover, in myotubes treated with interleukin-6, cachectic phenotype is associated with a fermentative metabolism, and the inhibition of lactate dehydrogenase by oxamate prevents cachectic features. The same results have been achieved by treating myotubes with conditioned media from human colon HCT116 and human pancreatic MIAPaCa-2 cancer cell lines, thus showing that what has been observed with murine-conditioned media is a wide phenomenon. These findings demonstrate that cachexia induction in myotubes is linked with a metabolic shift towards fermentation, and inhibition of lactate formation impedes cachexia and highlights lactate dehydrogenase as a possible new tool for counteracting the onset of this pathology.<\/jats:p>","DOI":"10.3390\/biomedicines9060698","type":"journal-article","created":{"date-parts":[[2021,6,20]],"date-time":"2021-06-20T22:00:02Z","timestamp":1624226402000},"page":"698","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A Metabolic Change towards Fermentation Drives Cancer Cachexia in Myotubes"],"prefix":"10.3390","volume":"9","author":[{"given":"Michele","family":"Mannelli","sequence":"first","affiliation":[{"name":"Dipartimento di Scienze Biomediche, Sperimentali e Cliniche \u201cM. Serio\u201d, Universit\u00e0 degli Studi di Firenze, Viale Morgagni 50, 50134 Firenze, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1489-8934","authenticated-orcid":false,"given":"Tania","family":"Gamberi","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze Biomediche, Sperimentali e Cliniche \u201cM. Serio\u201d, Universit\u00e0 degli Studi di Firenze, Viale Morgagni 50, 50134 Firenze, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8388-0952","authenticated-orcid":false,"given":"Francesca","family":"Magherini","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze Biomediche, Sperimentali e Cliniche \u201cM. Serio\u201d, Universit\u00e0 degli Studi di Firenze, Viale Morgagni 50, 50134 Firenze, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7321-3849","authenticated-orcid":false,"given":"Tania","family":"Fiaschi","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze Biomediche, Sperimentali e Cliniche \u201cM. Serio\u201d, Universit\u00e0 degli Studi di Firenze, Viale Morgagni 50, 50134 Firenze, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.trecan.2018.10.001","article-title":"Cancer Cachexia: More Than Skeletal Muscle Wasting","volume":"4","author":"Schmidt","year":"2018","journal-title":"Trends Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: Understanding the molecular basis","volume":"14","author":"Busquets","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/SPC.0000000000000382","article-title":"Preservation of muscle mass as a strategy to reduce the toxic effects of cancer chemotherapy on body composition","volume":"12","author":"Pin","year":"2018","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","article-title":"Understanding the mechanisms and treatment options in cancer cachexia","volume":"10","author":"Fearon","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1158\/1078-0432.CCR-16-0495","article-title":"Molecular Pathways: Cachexia Signaling\u2014A Targeted Approach to Cancer Treatment","volume":"22","author":"Miyamoto","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0165-6147(96)10021-3","article-title":"The ubiquitin-dependent proteolytic pathway in skeletal muscle: Its role in pathological states","volume":"17","year":"1996","journal-title":"Trends Pharm. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1152\/physrev.00027.2001","article-title":"The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction","volume":"82","author":"Glickman","year":"2002","journal-title":"Physiol. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/10409238.2013.857291","article-title":"Signaling pathways controlling skeletal muscle mass","volume":"49","author":"Egerman","year":"2014","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"ref_10","first-page":"871","article-title":"Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha","volume":"12","author":"Li","year":"1998","journal-title":"Faseb J."},{"key":"ref_11","first-page":"R659","article-title":"Cachectin\/TNF or IL-1 alpha induces cachexia with redistribution of body proteins","volume":"256","author":"Fong","year":"1989","journal-title":"Am. J. Physiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/SPC.0000000000000091","article-title":"Role of interleukin-6 in cachexia: Therapeutic implications","volume":"8","author":"Narsale","year":"2014","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia","volume":"303","author":"Bonetto","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3945\/ajcn.116.140434","article-title":"Relation between hypermetabolism, cachexia, and survival in cancer patients: A prospective study in 390 cancer patients before initiation of anticancer therapy","volume":"105","author":"Vazeille","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/ejcn.2016.96","article-title":"Key determinants of energy expenditure in cancer and implications for clinical practice","volume":"70","author":"Purcell","year":"2016","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3892\/ijo.2013.1998","article-title":"Skeletal muscle mitochondrial uncoupling in a murine cancer cachexia model","volume":"43","author":"Tzika","year":"2013","journal-title":"Int. J. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s13539-014-0154-x","article-title":"Cachexia: A problem of energetic inefficiency","volume":"5","author":"Toledo","year":"2014","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1038\/onc.2016.153","article-title":"Activation of the SDF1\/CXCR4 pathway retards muscle atrophy during cancer cachexia","volume":"35","author":"Martinelli","year":"2016","journal-title":"Oncogene"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1242\/dmm.010389","article-title":"Cellular and molecular mechanisms of muscle atrophy","volume":"6","author":"Bonaldo","year":"2013","journal-title":"Dis. Model. Mech."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: Mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1113\/jphysiol.2012.230185","article-title":"Biomarkers of mitochondrial content in skeletal muscle of healthy young human subjects","volume":"590","author":"Larsen","year":"2012","journal-title":"J. Physiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"14683","DOI":"10.1038\/s41598-018-33048-z","article-title":"How phosphorylation influences E1 subunit pyruvate dehydrogenase: A computational study","volume":"8","author":"Sgrignani","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"7778","DOI":"10.1096\/fj.201802799R","article-title":"PDK4 drives metabolic alterations and muscle atrophy in cancer cachexia","volume":"33","author":"Pin","year":"2019","journal-title":"Faseb J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1172\/JCI200420174","article-title":"Cancer cachexia is regulated by selective targeting of skeletal muscle gene products","volume":"114","author":"Acharyya","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fcell.2018.00090","article-title":"Beyond the Warburg Effect: How Do Cancer Cells Regulate One-Carbon Metabolism?","volume":"6","author":"Rosenzweig","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s13539-012-0101-7","article-title":"Metabolic derangements in the gastrocnemius and the effect of Compound A therapy in a murine model of cancer cachexia","volume":"4","author":"Wysong","year":"2013","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1016\/j.bbagen.2012.11.009","article-title":"Mitochondrial and sarcoplasmic reticulum abnormalities in cancer cachexia: Altered energetic efficiency?","volume":"1830","author":"Busquets","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.18632\/aging.100436","article-title":"Disruption of MEF2C signaling and loss of sarcomeric and mitochondrial integrity in cancer-induced skeletal muscle wasting","volume":"4","author":"Shum","year":"2012","journal-title":"Aging (Albany NY)"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1016\/j.jmb.2019.05.032","article-title":"Autophagy Exacerbates Muscle Wasting in Cancer Cachexia and Impairs Mitochondrial Function","volume":"431","author":"Penna","year":"2019","journal-title":"J. Mol. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.bbalip.2014.03.004","article-title":"Molecular insights into mitochondrial dysfunction in cancer-related muscle wasting","volume":"1841","author":"Antunes","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1113\/expphysiol.2013.072496","article-title":"Mitochondrial dysfunction and therapeutic approaches in respiratory and limb muscles of cancer cachectic mice","volume":"98","author":"Fermoselle","year":"2013","journal-title":"Exp. Physiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.biocel.2013.04.014","article-title":"Bladder cancer-induced skeletal muscle wasting: Disclosing the role of mitochondria plasticity","volume":"45","author":"Oliveira","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e47258","DOI":"10.15252\/embr.201847258","article-title":"Energy metabolism in cachexia","volume":"20","author":"Rohm","year":"2019","journal-title":"EMBO Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/jcsm.12360","article-title":"Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism","volume":"10","author":"Pin","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nm.4093","article-title":"Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia","volume":"22","author":"Fukawa","year":"2016","journal-title":"Nat. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"622","DOI":"10.15252\/emmm.201607052","article-title":"STAT3 promotes IFN\u03b3\/TNF\u03b1-induced muscle wasting in an NF-\u03baB-dependent and IL-6-independent manner","volume":"9","author":"Ma","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3292087","DOI":"10.1155\/2017\/3292087","article-title":"Disrupted Skeletal Muscle Mitochondrial Dynamics, Mitophagy, and Biogenesis during Cancer Cachexia: A Role for Inflammation","volume":"2017","author":"VanderVeen","year":"2017","journal-title":"Oxid Med. Cell Longev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.2337\/db05-1404","article-title":"Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase","volume":"55","author":"Carey","year":"2006","journal-title":"Diabetes"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s00424-013-1399-5","article-title":"Effects of IL-6 on pyruvate dehydrogenase regulation in mouse skeletal muscle","volume":"466","author":"Knudsen","year":"2014","journal-title":"Pflug. Arch."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0065-2571(01)00061-9","article-title":"Regulation of the activity of the pyruvate dehydrogenase complex","volume":"42","author":"Harris","year":"2002","journal-title":"Adv. Enzym. Regul."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"17807","DOI":"10.1073\/pnas.0803090105","article-title":"A catabolic block does not sufficiently explain how 2-deoxy-D-glucose inhibits cell growth","volume":"46","author":"Ralsera","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1042\/BCJ20170032","article-title":"Novel targeted therapies for cancer cachexia","volume":"474","author":"Stemmler","year":"2017","journal-title":"Biochem. J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4251\/wjgo.v7.i4.17","article-title":"Cancer cachexia, mechanism and treatment","volume":"7","author":"Aoyagi","year":"2015","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3389\/fonc.2019.01143","article-title":"Lactate in the regulation of tumor microenvironment and terapeuthic approaches","volume":"9","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1002\/cam4.1820","article-title":"Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy","volume":"7","author":"Feng","year":"2018","journal-title":"Cancer Med."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/6\/698\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:19:38Z","timestamp":1760163578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/6\/698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,20]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["biomedicines9060698"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9060698","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,20]]}}}